Cannula Market Size, Share & Trends Analysis Report Product Outlook (Cardiac (Arterial, Venous, Cardiograph, Femoral), Dermatology, Nasal, Others), Type Outlook (Neonatal cannulae, Straight cannulae, Winged cannulae, Wing with port, Winged with stop cork), Material Outlook (Plastic, Metal, Silicone), Size Outlook (14G, 16G, 18G, 20G, 22G, 24G, 26G), End-use Outlook (Hospital, Ambulatory Surgical Centers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Cannula Market Size & Trends

The global cannula market size was valued at USD 151.4 million in 2021 and is projected to reach USD 283.77 million by 2030 at a CAGR of 7.23% 2022 to 2030. Factors such as surge in cases of diabetes and obesity drives the cannula market demand by 2030.

A cannula is a small hollow tube with a sharp and retractable inner core that is inserted into a vein, artery, or another body cavity to administer medication and withdraw fluids. Various types of cannula are available for use in various procedures. For instance, an intravenous cannula is used to establish cardiopulmonary bypass during cardiac surgery. In a similar fashion, a nasal cannula is used to administer oxygen by passing the plastic tubing beneath the nose. In addition, it is frequently used for injecting fillers because it causes less pain, reduces the risk of bleeding and bruising, and offers greater flexibility than hypodermic needles. It is widely used in hospitals, ambulatory surgery centers (ASCs), blood banks, laboratories, and pathology labs on the world as a result of its numerous qualities.

Cannula Market Growth Factors

A Surge In Cases Of Diabetes And Obesity Drives The Market

Globally, over 234 million procedures are performed annually, per the National Center for Biotechnology Information. Medical cannulae are necessary for the administration of therapeutic and diagnostic chemicals, as well as anesthetic procedures, suction, and irrigation.

In addition, a substantial proportion of the population prefers minimally invasive procedures. According to the National Center for Biotechnology Information, proper surgical equipment (including medical cannulae) has the potential to prevent 6-7% of fatalities.

In recent years, worldwide obesity rates have risen dramatically. As a result of the increasing prevalence of lifestyle disorders such as obesity and diabetes, the number of surgical procedures performed around the world is increasing, thereby contributing to the development of the cannula industry.

In addition, the growing elderly population and the preference for minimally invasive procedures (MIS) are driving cannula market growth.

Minimally Invasive Surgeries Are Driving the Market

In the medical field, minimally invasive surgical procedures are gaining popularity. For the treatment of cardiovascular diseases, there has been a rapid rise in the popularity of minimally invasive procedures. This is due to the fact that minimally invasive procedures cause less surgical trauma and produce a more aesthetically pleasing outcome. It provides benefits such as smaller incisions, reduced risk of infection, smaller scars, less blood loss, and less pain and trauma. As a result, there is a growing preference for minimally invasive surgical procedures, which is anticipated to stimulate the market for cannulas.

Cannula Market Resrtraining Factors

A Shortage Of Trained Medical Professionals Hampers The Market

In surgical procedures, medical cannulae are unavoidable; however, improper cannulation can result in hypersensitivity, extravasation, infiltration, phlebitis, and systemic or local infections.

In addition, IV cannulation of a newborn could be excruciatingly unpleasant if not performed with care. In addition, only a handful of institutions around the world offer training in medical cannulation. Lack of competent labour and cannulation errors are likely to impede market expansion in the foreseeable future.

Market Opportunities

Ease of Manufacturing Will Bring In New Opportunities

In all regions, the use of syringes and cannulas is increasing in the healthcare industry. Due to the fact that these goods are simpler to produce than other medical equipment, there is a greater chance that more manufacturers will enter the market and earn substantial profits.

Relevant is also the fact that the market is highly fragmented, comprised of numerous regional and local firms. As a result, the industry is incredibly competitive, posing a threat to existing businesses. As a result, market leaders are continuously working on strategic developments and releasing new products, a factor that drives the market growth.

Regional Analysis

North America Dominates the Global Market

In 2021, North America dominated the market with the largest market share. This is due to the region's availability of sophisticated healthcare facilities and the presence of market leaders. In addition, the increasing prevalence of lifestyle diseases in the region contributes significantly to its dominance. Other factors, such as increased awareness of minimally invasive procedures and the rising rate of cosmetic surgery adoption in this region, also contribute to the expansion of the market in this area. The American Society of Plastic Surgeons estimates that approximately $16.7 billion will be spent on cosmetic procedures in the United States in 2020.

Asia-Pacific

Asia-Pacific is anticipated to experience lucrative growth during the forecast period as a result of a dramatic increase in the region's geriatric population, which creates a massive patient pool suffering from chronic diseases such as cardiovascular disease and diabetes. In addition, the government's increasing efforts to implement favourable policies to transform the healthcare sector, particularly in rural areas, are anticipated to further stimulate the market's expansion in this region.

Segmental Analysis

By Product

This market can be segmented on the basis of product, type, material, size, end-use, competitors and regions. The market for cannulas is divided into cardiac (arterial, venous, cardioplegia, and other) dermatology, nasal, and other segments. In 2021, the largest cannula market share was held by the cardiac segment. This is because of the prevalence of cardiovascular disease. The prevalence of cardiovascular disease is on the rise due to factors such as a shift toward a more sedentary lifestyle, increased consumption of processed foods, and a decline in physical activity. In addition, an increase in the geriatric population, which is at a higher risk of developing these diseases, also contributes to the dramatic rise in cardiovascular diseases. Consequently, the rise in the prevalence of cardiovascular diseases is the primary reason for the dominance of the cardiac segment in the global market.

The dermatology segment is anticipated to experience significant expansion during the projection period. This is because microcannula is used more frequently to prevent difficulties during and after surgeries. Additionally, there has been a noticeable increase in the number of aesthetic procedures performed, which is predicted to increase demand for the dermatology sector significantly. In the United States, physicians perform more than 15 million cosmetic surgery treatments annually, according to a research paper published in 2021. Thus, segment growth during the forecast period is anticipated to boost MIS penetration.

By Type

The market is segmented by type into neonatal cannulae, straight cannulae, winged cannulae, a wing with a port, and winged with a stop cork. In 2021, the segment of cannulae that are straight held the largest market share. This is due to the fact that its design makes it easier to use. The product's extra-sharp needle also facilitates insertion. As a result, these types of cannulae are utilized in cardiac surgeries in order to prevent any mishaps and reduce any unnecessary delays that could cause the procedure to be extended.

Neonatal cannulae are anticipated to see the highest growth and CAGR during the forecast period. The rise in the occurrence of respiratory issues in newborns is the main factor driving this segment's expansion. Neonatal cannulae are ideal for neonates in high-flow oxygen therapy because of their soft and flexible nature. In 2016, 33.3% of all newborn admissions at >28 weeks' gestation had respiratory issues as their primary reason for admission, excluding children with syndromes and those with congenital or surgical illnesses, according to a study released by the National Library of Medicine.

By Material

The market is segmented into plastic, metal, and silicone based on material. Due to its increased adoption rate in both in-patient and out-patient procedures, the plastics segment held the largest market share in 2021. In shoulder arthroscopy, the majority of plastic cannulas are translucent, enabling surgeons to see instruments and sutures passing through the cannula. As a result, it is suitable for use in the vast majority of procedures, which will lead to its dominance throughout the period being forecasted.

During the forecast period, the silicone segment is expected to experience the greatest growth. This is attributable to the increasing use of silicone cannulas in oxygen therapies, which ensure the continuous delivery of oxygen to surgical patients and those with respiratory disorders. In addition, silicone cannulas are soft and flexible, making them a popular choice among medical professionals and patients.

By Size

14G, 16G, 18G, 20G, 22G, 24G, and 26G are market segments based on size. Colors represent various sizes of cannulas. In 2021, the 18G size held the largest market share, a trend that is anticipated to continue throughout the forecast period. This is due to the fact that the 18G cannula size is the most commonly used in hospitals for both adults and adolescents. 18G cannulas are used to administer blood products and drugs. These cannulas are intended for speedy blood transfusion. In addition, these are utilized for protocols involving computed tomography/pulmonary embolism and other tests requiring large IV sizes.

The most significant increase is anticipated for 22 G-size cannulas, projected to expand at a sizable CAGR during the forecast period. This is explained by the narrow gauge size of the device, which enables a faster fluid flow in patients with intricate veins. Most patients are successfully treated with one long peripheral cannula throughout their treatment without needing additional cannulation, according to a research study published in the Journal of Vascular Access in 2018.

By Final Application

Based on the final application, the market is segmented into hospitals, ambulatory surgical centers, and others. Blood banks, research facilities, and pathology labs comprise the remainder of the market. On the basis of the final application, the market is segmented into hospitals, ambulatory surgical centres, and others. Blood banks, research facilities, and pathology labs make up the remainder of the market. In 2021, the largest market share was held by the hospital's segment. This is due to the increase in hospitalization rates for numerous causes and treatments. Cannulas are utilized in numerous hospital specialties, including orthopedic surgery, cardiovascular surgery, neurology, gynecology, general surgery, oxygen therapy, and dermatology.

The fastest growth is anticipated in ambulatory surgical centers over the predicted period. Modern healthcare facilities called ambulatory surgery centers to provide same-day surgical services in addition to preventive and diagnostic procedures. As a result, more people choose to have surgery at ambulatory surgical facilities rather than hospitals. As a result, there are more ambulatory surgery centers opening up. There are currently about 9,280 ambulatory surgery centers in the United States.

Impact of covid-19

Covid-19 had some profound adverse impacts on the global advanced ceramics market.

COVID-19 spread across the world from China, making the whole world stand still and to a complete lockdown situation. Covid-19 is an infectious disease that was caused by a newly discovered coronavirus. During the time, the fatality rate among the population above 40 was also high globally. The disease causes severe illness for people suffering from medical conditions like diabetes, cardiovascular disease, chronic respiratory disease, etc.

Considering the situation during that time, it was declared a pandemic which led to numerous countries, including the major economies like China, the United States, India, and others, implementing lockdowns which adversely affected the global economy.

In the first two quarters of 2020, the economic and industrial operations temporarily halted. Almost every manufacturing unit where advanced ceramics is used, such as electrical and electronics, transportation, industrial, chemical, and other End-user Industries (except medical), reduced their manufacturing capacities due to the lack of workers. The lockdown implemented put a halt to global supply chains. This resulted in repercussions in terms of both production and demand for advanced ceramics.

Market Recovery Timeline and Challenges

With time the lockdowns were uplifted, and relaxation was made to the public. Gradually, the economy picked up the pace and started its operations, bringing the demand in the global advanced ceramics market and increasing among various industries. As the situation improved during the initial months of 2021, the economies also strengthened their fiscal policies and initiated their development process; the end-user industries began their activities, bringing the overall ceramics market back on track.

Recent Developments

• In December 2022, the First patient in HugoTM robotic-assisted surgery system clinical study in the United States was announced by Medtronic.
• In January 2023, BD Introduced a Fully Automated Robotic Track System for Microbiology Labs.
• In December 2022, Acotec Scientific Holdings Limited's majority stake will be acquired by Boston Scientific through a strategic investment.